Iberogast

Iberogast, the active ingredient in Iberogast, is a herbal preparation presented as a liquid oral suspension for oral use. It is indicated for functional dyspepsia, irritable bowel syndrome and related gastrointestinal discomfort in adult patients. GNH USA supplies Iberogast as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring EU‑standard quality and reliable global distribution.

Iberogast is used to manage functional gastrointestinal disorders that affect the upper digestive tract.

Functional dyspepsia: alleviates upper abdominal pain, early satiety and bloating. Irritable bowel syndrome: reduces abdominal cramping and irregular bowel habits. Gastro‑oesophageal reflux: eases heartburn and regurgitation symptoms. Bloating: diminishes abdominal distension and discomfort. Upper abdominal discomfort: improves overall digestive comfort.

Iberogast may cause adverse reactions, which are reported as either common or serious.

Common Side Effects: - Mild abdominal discomfort - Nausea - Taste alteration

Serious or Rare Side Effects: - Allergic skin reactions (rash, itching) - Anaphylaxis (rare) - Liver enzyme elevation

Before using Iberogast, consider the following precautions.

Pregnancy: safety not established; avoid unless benefits outweigh risks. Breastfeeding: insufficient data; consider potential risk to infant. Liver disease: monitor hepatic function during therapy. Elderly: use with caution due to possible increased sensitivity. Drug interactions: review all concomitant medications. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Iberogast can interact with other medicines; assess the level of concern.

Major Interactions (Avoid): - Concomitant use with potent CYP450 inhibitors: may increase exposure to herbal constituents. - Co‑administration with anticoagulants (e.g., warfarin): heightened risk of bleeding.

Moderate Interactions (Monitor Closely): - Use with antacids: may alter absorption of active extracts. - Combination with other pro‑kinetic agents: monitor for excessive gastrointestinal motility. - Concurrent use with other herbal products containing similar extracts: assess cumulative effects.